Hereditary Cancer Testing Market Shoot Up to US$ 9,840.52 Mn Revenue by 2027 with Business Market Insights: Cancer Genetics Inc., Invitae Corporation, Myogenes, Strand Life Sciences Pvt. Ltd., Pathway Genomics Corporation, CENTOGENE AG

The Hereditary Cancer Testing Market is US$ 3,967.74 Mn in 2018 and is predicted to grow at a CAGR of 11.1% during the forecast period 2019 – 2027, to reach US$ 9,840.52 Mn by 2027.

The market for hereditary cancer testing is expected to grow, owing to factors such as the increasing prevalence of hereditary cancer and growing awareness about hereditary cancer have been boosting the market over the years. In addition, the growing demand for noninvasive methods of detection is likely to have a positive impact on the growth of the market in the coming years.

Cancer is a genetic disorder caused due to definite variations in genes that govern cell functioning, particularly affecting their growth and replication. Hereditary genetic mutations are the cause of ~5–10% of all cancers. The researchers have related mutations in particular genes with more than 50 hereditary cancer syndromes affecting individuals in developing certain cancers. According to the World Health Organization, cancer caused ~9.6 million deaths worldwide in 2018. Further, as per the prediction of the National Cancer Institute, in 2018, ~1,735,350 new cancer cases would be diagnosed in the US. The increasing prevalence of breast cancer in the world is a huge concern.

(**Note: The sample of this report is updated with COVID-19 impact analysis**)

Download a sample of this Market report now!
https://www.theinsightpartners.com/sample/TIPRE00006578/?source=openpr-10411

Leading Hereditary Cancer Testing Market Giants :-
Hologic Inc., Koninklijke Philips N.V., Quest Diagnostics Incorporated, Myriad Genetics, Inc., Cancer Genetics Inc., Invitae Corporation, Myogenes, Strand Life Sciences Pvt. Ltd., Pathway Genomics Corporation, and CENTOGENE AG, among others.

HEREDITARY CANCER TESTING – MARKET SEGMENTATION
Hereditary Cancer Testing Market By Diagnosis Type:
• Biopsy
o Blood Sample
o Cheek Swab Sample
• Imaging

Hereditary Cancer Testing Market By Technology:
• Sequencing
• PCR
• Microarray

Hereditary Cancer Testing Market By End User:
• Diagnostic Centers
• Hospital
• Clinics

BY GEOGRAPHY
• North America
o U.S.
o Canada
o Mexico
• Europe
o France
o Germany
o UK
o Spain
o Italy
• Asia Pacific (APAC)
o China
o India
o Japan
o Australia
o South Korea
• Middle East & Africa (MEA)
o Saudi Arabia
o South Africa
o UAE
• South and Central America
o Brazil
o Argentina

The Hereditary Cancer Testing Market report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends is discussed along with the competitive landscape in various regions, which would help top and emerging market players to determine the lucrative investment pockets.

The report begins with a brief introduction and market overview, in which the Hereditary Cancer Testing Market is first defined before estimating its market scope and size. Next, the report elaborates on the market scope and market size estimation. This is followed by an overview of the market segmentation such as type, application, and region. The drivers, limitations, and opportunities are listed for the Hereditary Cancer Testing industry, followed by industry news and policies.

Purchase a copy of the report @
https://www.theinsightpartners.com/buy/TIPRE00006578/?source=openpr-10411

The Insight Partners recognizes the manufacturing base, productivity and financial aspects of the global Hereditary Cancer Testing Market. This statistical report covers a wide-ranging examination of the global market to make well-informed business decisions.

If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.